The plant matrix of Artemisia annua L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies
PLOS One · 2025
DOI: 10.1371/journal.pone.0322835 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Fujie Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Artemisia annua, Antimalarials, Malaria, Plant Extracts. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major National Science and Technology Program of China for Innovative Drugs.
Abstract (Originalsprache)
Artemisinin-based combination therapies (ACTs) constitute the principal strategy for combating malaria in contemporary times, and research into the multifaceted components of Artemisia annua L. ( A. annua ) has garnered widespread interest among scientists. The aim of this study was to prepare A. annua extracts (nACTs) and to explore whether nACTs have higher bioavailability and efficacy than artemisinin (ART) alone due to its multiple bioactive components. Initially, the in vivo antimalarial activity of nACTs was evaluated by two murine malaria models. The results revealed that the antimalarial effect of nACTs was about 10-fold higher than that of ART alone when administered at the same dosage of ART. Then, we analyzed the pharmacokinetic characteristics of nACTs in rat plasma. Remarkably, nACTs exhibited significantly enhanced oral bioavailability, longer half-life as well as extended mean retention time in rats. In addition, the impact of nACTs on P-glycoprotein (P-gp) was evaluated using the Caco-2 cell line. The results showed that both ART and nACTs reduced the efflux rate of the P-gp substrate rhodamine 123 (R123) and induced the expression of P-gp in Caco-2 cells over a range of concentrations. nACTs had certain components-deoxyartemisinin (DEART), artemisinic acid (AA), and dihydroartemisinic acid (DHAA)-that inhibited the efflux and translocation of P-gp and facilitated the reduction of ART efflux. In conclusion, A. annua extracts significantly improved the antimalarial efficacy and bioavailability compared with ART.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of TCM Collateral Disease Theory Research, School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
- Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
ORCID-Profile: Manyuan Wang
Förderung
- National Natural Science Foundation of China
- Major National Science and Technology Program of China for Innovative Drugs
Zitieren
APA
Xu, F., Shan, X., Li, J., Li, J., Yuan, J., Zou, D., & Wang, M. (2025). The plant matrix of Artemisia annua L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies. PLOS One. https://doi.org/10.1371/journal.pone.0322835
Vancouver
Xu F, Shan X, Li J, Li J, Yuan J, Zou D, et al. The plant matrix of Artemisia annua L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies. PLOS One. 2025. doi:10.1371/journal.pone.0322835
BibTeX
@article{Xu2025,
author = {Xu, Fujie and Shan, Xiaohang and Li, Jialin and Li, Jing and Yuan, Jiqiao and Zou, Daozeng and Wang, Manyuan},
title = {The plant matrix of Artemisia annua L. for the treatment of malaria: Pharmacodynamic and pharmacokinetic studies},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0322835}
}
EUVIMED